• Home
  • Content Owner
  • Research

Intrauterine contraception: why are so few Australian women using this effective method

Reference

Bateson D, Harvey C, Williams J, Black KI, 2011, Intrauterine contraception: why are so few Australian women using this effective method, Med J Aust, 194(6) 324

Do women and providers value the same features of contraceptive products

Reference

Weisberg E, Bateson D, Knox S, Haas M, Viney R, Street D & Fiebig D, 2013, Do women and providers value the same features of contraceptive products, Eur J Contracept Reprod Health Care, 18(3) 181-90

Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen

Reference

Fraser IS, Weisberg E, Brache V, Alvarez F, Massai R, Mishell DR Jr, Apter D, Gale J, Tsong YY, Sivin I, 2005, Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen, Contraception, 72(1) 40-5

HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice

Reference

McCaffery KJ, Irwig L, Chan SF, Macaskill P, Barratt A, Lewicka M, Clarke J, Weisberg E, 2008, HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice, Patient Educ Couns, 73(3) 473-9, 481

OCs and community failure rate: what can the GP do to reduce it?

Reference

Weisberg E, 1994, OCs and community failure rate: what can the GP do to reduce it?, Curr Ther (Seaforth), 35(9) 47-8, 51-2

What's Good and Bad About Contraceptive Products?: A Best-Worst Atrribute Experiment Comparing the Values of Women Consumers and GPs

Reference

Knox SA, Viney RC, Street DJ, Haas MR, Fiebig DG, Weisberg E, Bateson D, 2012, What's Good and Bad About Contraceptive Products?: A Best-Worst Atrribute Experiment Comparing the Values of Women Consumers and GPs, Pharmacoeconomics, 30(12) 1187-202

Judaism and women's health

Reference

Weisberg E, Kern I, 2009, Judaism and women's health, J Fam Plann Reprod Health Care, 35(1) 53-5

A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings

Reference

Fraser IS, Weisberg E, Minehan E, Johansson ED, 2000, A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings, Contraception, 61(4) 241-51

Cervical cancer screening - the good news at last

Reference

Free A, Weisberg E, 1991, Cervical cancer screening - the good news at last, Australian Family Physician, 20(10) 1401+

Choosing an oral contraceptive

Reference

Weisberg E, 1988, Choosing an oral contraceptive, Aust Fam Physician, 17(10) 859-66

Pages

Share this page:

Intrauterine contraception: why are so few Australian women using this effective method

Reference

Bateson D, Harvey C, Williams J, Black KI, 2011, Intrauterine contraception: why are so few Australian women using this effective method, Med J Aust, 194(6) 324

Do women and providers value the same features of contraceptive products

Reference

Weisberg E, Bateson D, Knox S, Haas M, Viney R, Street D & Fiebig D, 2013, Do women and providers value the same features of contraceptive products, Eur J Contracept Reprod Health Care, 18(3) 181-90

Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen

Reference

Fraser IS, Weisberg E, Brache V, Alvarez F, Massai R, Mishell DR Jr, Apter D, Gale J, Tsong YY, Sivin I, 2005, Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen, Contraception, 72(1) 40-5

HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice

Reference

McCaffery KJ, Irwig L, Chan SF, Macaskill P, Barratt A, Lewicka M, Clarke J, Weisberg E, 2008, HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice, Patient Educ Couns, 73(3) 473-9, 481

OCs and community failure rate: what can the GP do to reduce it?

Reference

Weisberg E, 1994, OCs and community failure rate: what can the GP do to reduce it?, Curr Ther (Seaforth), 35(9) 47-8, 51-2

What's Good and Bad About Contraceptive Products?: A Best-Worst Atrribute Experiment Comparing the Values of Women Consumers and GPs

Reference

Knox SA, Viney RC, Street DJ, Haas MR, Fiebig DG, Weisberg E, Bateson D, 2012, What's Good and Bad About Contraceptive Products?: A Best-Worst Atrribute Experiment Comparing the Values of Women Consumers and GPs, Pharmacoeconomics, 30(12) 1187-202

Judaism and women's health

Reference

Weisberg E, Kern I, 2009, Judaism and women's health, J Fam Plann Reprod Health Care, 35(1) 53-5

A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings

Reference

Fraser IS, Weisberg E, Minehan E, Johansson ED, 2000, A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings, Contraception, 61(4) 241-51

Cervical cancer screening - the good news at last

Reference

Free A, Weisberg E, 1991, Cervical cancer screening - the good news at last, Australian Family Physician, 20(10) 1401+

Choosing an oral contraceptive

Reference

Weisberg E, 1988, Choosing an oral contraceptive, Aust Fam Physician, 17(10) 859-66

Pages

Share this page: